{"url_path":"/sec/mmed/10-k/2026/item-15","section_key":"item-15","section_title":"Item 15 Exhibits and Financial Statement Schedules.","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/2062583/0001628280-26-045915-index.html","accession_number":"0001628280-26-045915","cik":"0002062583","ticker":"MMED","issuer_name":"MiniMed Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2062583/0001628280-26-045915-index.html","primary_entity_key":"0002062583","primary_entity_name":"MiniMed Group, Inc."},"word_count":1050,"has_tables":true,"body_markdown":"Item 15. Exhibits and Financial Statement Schedules.\n\n1.Financial Statements and Schedules\n\nThe required information is set forth in “Part II, Item 8 – Financial Statements and Supplementary Data” in this Annual Report.\n\n2.Exhibits\n\nThe exhibits listed below are filed as part of this Annual Report or incorporated herein by reference to the location indicated.\n\nEXHIBIT INDEX\n\nIncorporated by Reference\nProvided Herewith\n\nExhibit No.Description\nForm\n\nFile No.\n\nDate of First Filing\n\nExhibit No.\n\n3.1\n[Second Amended and Restated Certificate of Incorporation of MiniMed Group, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit31-8xk.htm)\n\n8-K\n\n001-43183\n\nMarch 9, 2026\n\n3.1\n\n3.2\n[Amended and Restated Bylaws of MiniMed Group, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit32-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n\n3.2\n\n4.1\n[Description of Securities](exhibit41-descriptionofsec.htm)\nX\n\n10.1 #\n[Separation Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit101-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.1\n\n10.2 #\n[Tax Matters Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit102-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.2\n\n10.3 #\n[Employee Matters Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit103-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.3\n\n10.4 #\n[MGH-MM Intellectual Property Cross-License Agreement, dated as of March 1, 2026, by and between Medtronic MiniMed, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit104-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.4\n\n10.5 #\n[MPLC-MHSS Intellectual Property Cross-License Agreement, dated as of March 1, 2026, by and between MiniMed Holdings Switzerland Sarl and Medtronic plc](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit105-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.5\n\n10.6 #\n[Transitional Trademark Cross-License Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit106-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.6\n\n10.7 #\n[Co-Existence Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit107-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.7\n\n10.8 #\n[Transition Services Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic Group Holding, Inc. #](https://www.sec.gov/Archives/edgar/data/0002062583/000162828026016018/exhibit108-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.8\n\n10.9\n[Registration Rights Agreement, dated as of March 1, 2026, by and between Kangaroo US HoldCo 2, Inc. and Medtronic plc](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit109-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.9\n\n10.10 #\n[Lease Agreement, dated as of March 1, 2026, by and between MiniMed Puerto Rico Operations LLC and Medtronic Puerto Operations Co.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1010-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.10\n\n10.11#\n[Master Services Agreement, dated as of March 1, 2026, by and between MiniMed Puerto Rico Operations LLC and Medtronic Puerto Operations Co.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1011-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.11\n\n10.12 #\n[Transition Manufacturing and Supply Agreement, dated as of March 1, 2026, by and between Medtronic MiniMed, Inc. and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/0002062583/000162828026016018/exhibit1012-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.12\n\n10.13 †\n[MiniMed Group, Inc. Non-Employee Director Compensation Policy](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1013-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.13\n\n10.14 †\n[Form of Non-Employee Director RSU Award Agreement](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1014-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.14\n\n10.15 †\n[MiniMed Group, Inc. Long Term Incentive Plan](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1015-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.15\n\n10.16 †\n[Form of IPO NQSO Award Agreement](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1016-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.16\n\n152\n\n10.17 †\n[Form of IPO PSU Award Agreement](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1017-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.17\n\n10.18 †\n[MiniMed Group, Inc. Employee Stock Purchase Plan](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1018-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.18\n\n10.19 # †\n[MiniMed Group, Inc. Capital Accumulation Plan](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1019-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.19\n\n10.20 # †\n[MiniMed Group, Inc. Nonqualified Retirement Plan Supplement](https://www.sec.gov/Archives/edgar/data/2062583/000162828026016018/exhibit1020-8xk.htm)\n\n8-K\n001-43183\nMarch 9, 2026\n10.20\n\n10.21 +\n[Integration, Supply and Distribution Agreement, dated as of July 31, 2024, by and between Abbott Diabetes Care, Inc. and Medtronic MiniMed, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1012-sx1.htm)\nS-1333-292284December 19, 202510.12\n\n10.22 #\n[Credit Agreement, dated as of January 15, 2026, by and among Kangaroo US HoldCo 2, Inc., the lenders party thereto, and Citibank N.A. as administrative agent and collateral agent.](https://www.sec.gov/Archives/edgar/data/2062583/000162828026003281/exhibit1013-sx1a1.htm)\nS-1333-292284January 23, 202610.13\n\n10.23 †\n[Letter of Intent, dated March 21, 2025, by and between Que Dallara and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1014-sx1.htm)\nS-1333-292284December 19, 202510.14\n\n10.24 †\n[Letter of Intent, dated May 28, 2025, by and between Chad Spooner and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1015-sx1.htm)\nS-1333-292284December 19, 202510.15\n\n10.25 †\n[Letter of Intent, dated April 24, 2025, by and between Ali Dianaty and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1016-sx1.htm)\nS-1333-292284December 19, 202510.16\n\n10.26 †\n[Letter of Intent, dated May 28, 2025, by and between Courtney Nelson Wills and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1017-sx1.htm)\nS-1333-292284December 19, 202510.17\n\n10.27 †\n[Letter of Intent, dated May 23, 2025, by and between Gillian Chandrasena and Medtronic, Inc.](https://www.sec.gov/Archives/edgar/data/2062583/000162828025058231/exhibit1018-sx1.htm)\nS-1333-292284December 19, 202510.18\n\n10.28 †\n[MiniMed Group, Inc. Severance Pay Plan for Executives](exhibit1028-severancepaypl.htm)\nX\n\n10.29 †\n[MiniMed Group, Inc. Change of Control Severance Plan](exhibit1029-changeofctrlse.htm)\nX\n\n10.30 †\n[Form of Employee RSU Award Agreement](exhibit1030-formofemployee.htm)\nX\n\n10.31 †\n[Form of Perfo](exhibit1031-formofperforma.htm)[rmance](exhibit1031-formofperforma.htm)[-Based PSU Agreement](exhibit1031-formofperforma.htm)\nX\n\n10.32+\n[First Amendment to Integration, Supply and Distribution Agreement, dated as of June 1, 2026, by and between Abbott Diabetes Care, Inc. and Medtronic MiniMed, Inc.](exhibit1032-firstamendment.htm)\nX\n\n10.33+\n[Second Amendment to Integration, Supply and Distribution Agreement, dated as of June 1, 2026, by and between Abbott Diabetes Care, Inc. and Medtronic MiniMed, Inc.](exhibit1033-secondamendmen.htm)\nX\n\n19.1\n[MiniMed Group, Inc. Global Insider Trading Policy](exhibit191-globalinsidertr.htm)\nX\n\n21.1\n[Subsidiaries of MiniMed Group, Inc.](mmed-2026q410kxex211.htm)\nX\n\n23.1\n[Consent of Independent Registered Public Accounting Firm](exhibit231-consentofindepe.htm)\nX\n\n24.1\n[Power of Attorney](exhibit241-powerofattorney.htm)\nX\n\n31.1\n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](mmed-2026q410kxex311.htm)\nX\n\n31.2\n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](mmed-2026q410kxex312.htm)\nX\n\n32.1\n[Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](mmed-2026q410kxex321.htm)\nX\n\n32.2\n[Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](mmed-2026q410kxex322.htm)\nX\n\n97.1\n[MiniMed Group, Inc. Policy for the Recovery of Erroneously Awarded Compensation](exhibit971-policyfortherec.htm)\nX\n\n101.SCHInline XBRL Schema Document.X\n\n101.CALInline XBRL Calculation Linkbase Document.X\n\n101.DEFInline XBRL Definition Linkbase Document.X\n\n101.LABInline XBRL Label Linkbase Document.X\n\n101.PREInline XBRL Presentation Linkbase Document.X\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)X\n\n153\n\n† Indicates management contract or compensatory plan.\n\n+ Certain portions of the exhibit have been redacted pursuant to Item 601(b)(10) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.\n# Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon its request.\n\n154"}